Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Why Biohaven Stock Zoomed More Than 6% Higher Today
Via The Motley Fool
Topics Regulatory Compliance
Tickers BHVN RY TSX:RY
Exposures Legal Product Safety Regulatory
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
Via Investor Brand Network
Tickers NRXP
Exposures Product Safety
Kaplan Fox Encourages Investors of Unicycive Therapeutics, Inc. (UNCY) to Contact the Firm Before Lead Plaintiff Deadline on October 14, 2025
Via TheNewswire.com
Topics Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Kaplan Fox Encourages Investors of Unicycive Therapeutics, Inc. (UNCY) to Contact the Firm Before Lead Plaintiff Deadline on October 14, 2025
Via NewMediaWire
Topics Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Retail Traders Pile Into Ionis As Wall Street Hikes Price Targets On FDA Approval Of Swelling Disorder Therapy
Via Stocktwits
Tickers IONS
Exposures Product Safety
What's Going On With Takeda Stock On Friday?
Via Benzinga
Tickers IONS TAK
Exposures Product Safety
Biohaven Surges After FDA Cancels Key Meeting. But Is It Good News?
Via Investor's Business Daily
Tickers BHVN RY TSX:RY
Exposures Product Safety
October 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against UNCY
Via NewMediaWire
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Replimune Group, Inc. (REPL) Shareholders
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
September 15, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
September 15, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Announces the Filing of a Securities Class Action on Behalf of Replimune Group, Inc. (REPL) Shareholders
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
October 14, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against UNCY
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Biohaven Advances Toward Potential First FDA-Approved Therapy For Spinocerebellar Ataxia, FDA Drops Advisory Meeting
Via Benzinga
Tickers BHVN CAPR
Exposures Product Safety
Novavax Stock Suffers Sharpest Drop In Months After $225M Debt Deal; Retail Still Leans Bullish
Via Stocktwits
Tickers BAC NVAX
Exposures COVID-19 Product Safety
Turnaround Strategy Drives Rapid Growth For OTC Hearing Aid Company In 2025
Via Press Release Distribution Service
Tickers VZ
Exposures Product Safety
Trading Radar For August 22: Wipro, Apollo Hospitals, HUL, Hikal, Vedanta, GMR Airports Are On Stocks Watchlist
Via Stocktwits
Topics Economy Government World Trade
Exposures Interest Rates Political Product Safety
Retail Buzz Builds As Vanda Urges FDA Chief To Revisit Hetlioz Generics Decision — Alleges “Bias Toward Approvals”
Via Stocktwits
Topics Retirement
Tickers VNDA
Exposures Pension Product Safety
Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 2Q25
Via Newsfile
Tickers CING
Exposures Product Safety
Ionis Pharma Wins FDA Nod For First RNA-Targeted Therapy For Rare Genetic Swelling Disorder
Via Benzinga
Tickers BCRX CSLLY IONS KALV TAK
Exposures Product Safety
Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years
Via Benzinga
Tickers ACHV PFE
Exposures Product Safety
Local Coach Shares Life Lessons in New Book
Via GlobePRwire
Topics Product Recall
Exposures Legal Product Safety
Liposomal NMN vs. Standard NMN: What One Needs to Know
Via AB Newswire
Exposures Product Safety
Clene Inc. (NASDAQ: CLNN) Reports Q2 2025 Results as Company Prepares for NDA Submission and Extends Runway into 2026
Via Investor Brand Network
Tickers BMWYY CLNN
Exposures Product Safety
Sarepta Just Got A Good Restructuring Deal For $700M Debt, But Stock Tumbles 7% – Here’s Why
Via Stocktwits
Tickers BAC DWSH EAOR SRPT
Exposures Product Safety
Investors in Unicycive Therapeutics, Inc. Should Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY
Via NewMediaWire
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 15, 2025 in Capricor Therapeutics, Inc. Lawsuit - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Investors in Unicycive Therapeutics, Inc. Should Contact Levi &amp; Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
September 22, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 15, 2025 in Capricor Therapeutics, Inc. Lawsuit - CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.